Bioengineering professor and The Grainger College of Engineering’s Dean, Rashid Bashir, led a team of researchers in a project that’s resulted in new technology that offers rapid, highly sensitive detection of multi-drug-resistant bacteria and other pathogens at low concentrations.
Updated: Sanofi’s $1.5B pact with Teva in IBD adds fuel to anti-TL1A race against Merck, Roivant and Pfizer
Sanofi wasn’t the only party interested in Teva’s anti-TL1A antibody, but it emerged as the “perfect partner” to secure a deal worth up to $1.5